MIF levels are associated with an increased incidence of prostate cancer [69], non small cell lung cancer [31], squamous cell carcinomas of the nasopharynx [70] and esophagus [71], breast cancer [72], colorectal cancer [73], hepatocellular carcinoma [74] and several other cancers [75]. This evidence concerns the gene MIF and non-small cell lung carcinoma.